Dr. Michael J. Krabak, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- State University of New York at Buffalo School of Medicine (1994)
- Years since graduation
- 32
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 276
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1994Medical school: State University of New York at Buffalo School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
NY license 218067
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Kaleida Health Buffalo, NY
- Sisters of Charity Hospital Buffalo, NY
- Kenmore Mercy Hospital Kenmore, NY
Medical groups
- Rpci Oncology, PC (65 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 276
- Services billed
- 69,891
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, dexamethasone sodium phosphate, 1 mg | 636 | 17 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 499 | 93 |
| Established patient office or other outpatient visit, 30-39 minutes | 298 | 150 |
| Insertion of needle into vein for collection of blood sample | 285 | 78 |
| Established patient office or other outpatient visit, 20-29 minutes | 253 | 169 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 170 | 19 |
| Administration of chemotherapy into vein, 1 hour or less | 153 | 15 |
| Injection of drug or substance under skin or into muscle | 129 | 11 |
| Established patient office or other outpatient visit, 40-54 minutes | 43 | 31 |
| New patient office or other outpatient visit, 60-74 minutes | 42 | 42 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Hydroxyurea Other prescribers in Williamsville, NY | 123 |
| Letrozole Other prescribers in Williamsville, NY | 53 |
| Eliquis (apixaban) Other prescribers in Williamsville, NY | 41 |
| Xarelto (rivaroxaban) Other prescribers in Williamsville, NY | 33 |
| Calquence (acalabrutinib maleate) | 30 |
| Dexamethasone Other prescribers in Williamsville, NY | 27 |
| Allopurinol Other prescribers in Williamsville, NY | 26 |
| Anastrozole Other prescribers in Williamsville, NY | 24 |
| Alendronate Sodium Other prescribers in Williamsville, NY | 23 |
| Prochlorperazine Maleate Other prescribers in Williamsville, NY | 22 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 28 companies reported 62 payments worth $2,015 in total to this clinician.
| Incyte Corporation | $324 |
|---|---|
| AbbVie Inc. | $293 |
| Pfizer Inc. | $193 |
| Novartis Pharmaceuticals Corporation | $168 |
| Medtronic, Inc. | $161 |
| Syndax Pharmaceuticals, Inc. | $120 |
| Seagen Inc. | $92.99 |
| Genzyme Corporation | $76.54 |
| Food and Beverage | $1,823 |
|---|---|
| Education | $192 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Incyte Corporation Jan 16, 2025 | Education | $99.00 |
| Seagen Inc. May 14, 2025 | Education in-kind | $92.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.